StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN), Pfizer (PFE) Comment on U.S. Treasury Action; Won't Comment on Potential Impact
April 5, 2016 6:37 AM
Pfizer Inc. (NYSE: PFE) and Allergan plc (NYSE: AGN) issued ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Litigation
Next Articles
BMO Capital Reiterates Outperform on Pfizer (PFE) Following Allergan Merger Termination
April 6, 2016 10:42 AM
Leerink Partners Cuts Price Target on Allergan (AGN) Following New U.S. Treasury Regulations
April 6, 2016 7:13 AM
Allergen's (AGN) Stand-Alone Price Target is $282 at Deutsche Bank
April 5, 2016 3:45 PM
Buy Allergen (AGN) at $220 Regardless of Deal Outcome - Leerink
April 5, 2016 8:54 AM
Treasury Action More than a Wrinkle for Pfizer (PFE)/Allergan (AGN) Deal - Jefferies
April 5, 2016 7:19 AM
New Treasury Action Could Block, or Significantly Change Pfizer (PFE)/Allergan (AGN) Deal - BMO Capital
April 5, 2016 6:53 AM
Pfizer and Allergan Issue Statement
April 4, 2016 7:05 PM
Pfizer (PFE) Conducting Review of U.S. Treasury Notice, Won't Speculate on Potential Effect - Bloomberg, Citing Spokeswoman
April 4, 2016 5:53 PM
UPDATE: Allergan (AGN) Pressured After U.S. Treasury, IRS Seek to Reduce Benefits of Inversions
April 4, 2016 5:24 PM
Allergan (AGN) Slammed on New U.S. Treasury Inversion Action; Pfizer (PFE) Higher
April 4, 2016 5:24 PM
Wall Street pulls back after recent rally
April 4, 2016 7:24 AM
